These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 21630030)
1. Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based method. Aklillu E; Mugusi S; Ngaimisi E; Hoffmann MM; König S; Ziesenitz V; Mikus G; Haefeli WE; Weiss J Eur J Clin Pharmacol; 2011 Nov; 67(11):1139-45. PubMed ID: 21630030 [TBL] [Abstract][Full Text] [Related]
2. Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population. Pasanen MK; Backman JT; Neuvonen PJ; Niemi M Eur J Clin Pharmacol; 2006 Jun; 62(6):409-15. PubMed ID: 16758257 [TBL] [Abstract][Full Text] [Related]
3. Direct and rapid genotyping of SLCO1B1 388A>G and 521T>C in human blood specimens using the SmartAmp-2 method. Yoshida K; Takano J; Ishizu Y; Lezhava A; Ieiri I; Maeda K; Hayashizaki Y; Sugiyama Y AAPS J; 2013 Apr; 15(2):618-22. PubMed ID: 23471819 [TBL] [Abstract][Full Text] [Related]
4. SLCO1B1 Gene Variations Among Tanzanians, Ethiopians, and Europeans: Relevance for African and Worldwide Precision Medicine. Aklillu E; Habtewold A; Ngaimisi E; Yimer G; Mugusi S; Amogne W; Reuter T; Meid A; Hoffmann MM; Weiss J OMICS; 2016 Sep; 20(9):538-45. PubMed ID: 27631193 [TBL] [Abstract][Full Text] [Related]
5. Comparison of SLCO1B1 sequence variability among German, Turkish, and African populations. Mwinyi J; Köpke K; Schaefer M; Roots I; Gerloff T Eur J Clin Pharmacol; 2008 Mar; 64(3):257-66. PubMed ID: 18185926 [TBL] [Abstract][Full Text] [Related]
6. Rapid identification of three functionally relevant polymorphisms in the OATP1B1 transporter gene using Pyrosequencing. Rohrbacher M; Kirchhof A; Skarke C; Geisslinger G; Lötsch J Pharmacogenomics; 2006 Mar; 7(2):167-76. PubMed ID: 16515396 [TBL] [Abstract][Full Text] [Related]
7. Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients. Yang GP; Yuan H; Tang B; Zhang W; Wang LS; Huang ZJ; Ou-Yang DS; Zhang GX; Zhou HH Acta Pharmacol Sin; 2010 Mar; 31(3):382-6. PubMed ID: 20140004 [TBL] [Abstract][Full Text] [Related]
8. No impact of SLCO1B1 521T>C, 388A>G and 411G>A polymorphisms on response to statin therapy in the Greek population. Giannakopoulou E; Ragia G; Kolovou V; Tavridou A; Tselepis AD; Elisaf M; Kolovou G; Manolopoulos VG Mol Biol Rep; 2014 Jul; 41(7):4631-8. PubMed ID: 24668570 [TBL] [Abstract][Full Text] [Related]
9. Lack of association between SLCO1B1 polymorphism and the lipid-lowering effects of atorvastatin and simvastatin in Chinese individuals. Fu Q; Li YP; Gao Y; Yang SH; Lu PQ; Jia M; Zhang LR Eur J Clin Pharmacol; 2013 Jun; 69(6):1269-74. PubMed ID: 23263738 [TBL] [Abstract][Full Text] [Related]
10. Effects of single nucleotide polymorphisms and haplotypes of the SLCO1B1 gene on the pharmacokinetic profile of atorvastatin in healthy Macedonian volunteers. Daka A; Dimovski A; Kapedanovska A; Vavlukis M; Eftimov A; Labachevski N; Jakjovski K; Geshkovska MN; Nebija D; Mladenovska K Pharmazie; 2015 Jul; 70(7):480-8. PubMed ID: 26373210 [TBL] [Abstract][Full Text] [Related]
11. Duplex pyrosequencing assay of the 388A>G and 521T>C SLCO1B1 polymorphisms in three Asian populations. Kim EY; Cho DY; Shin HJ; Lee SS; Shon JH; Shin JG; Shin SG Clin Chim Acta; 2008 Feb; 388(1-2):68-72. PubMed ID: 17996736 [TBL] [Abstract][Full Text] [Related]
12. SLCO1B1 c.521T>C Genotyping in the Austrian Population Using 2 Commercial Real-Time Polymerase Chain Reaction Assays: An Implementation Study. Enko D; Harringer S; Oberkanins C; Pühringer H; Halwachs-Baumann G; Kriegshäuser G Pharmacology; 2018; 102(1-2):88-90. PubMed ID: 29969773 [TBL] [Abstract][Full Text] [Related]
13. The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men. Kohlrausch FB; de Cássia Estrela R; Barroso PF; Suarez-Kurtz G Br J Clin Pharmacol; 2010 Jan; 69(1):95-8. PubMed ID: 20078617 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response. Rodrigues AC; Perin PM; Purim SG; Silbiger VN; Genvigir FD; Willrich MA; Arazi SS; Luchessi AD; Hirata MH; Bernik MM; Dorea EL; Santos C; Faludi AA; Bertolami MC; Salas A; Freire A; Lareu MV; Phillips C; Porras-Hurtado L; Fondevila M; Carracedo A; Hirata RD Int J Mol Sci; 2011; 12(9):5815-27. PubMed ID: 22016628 [TBL] [Abstract][Full Text] [Related]
15. SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals. Prado Y; Saavedra N; Zambrano T; Lagos J; Rosales A; Salazar LA Int J Mol Sci; 2015 Aug; 16(9):20609-19. PubMed ID: 26334272 [TBL] [Abstract][Full Text] [Related]
16. SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in Southern Brazilians. Sortica VA; Fiegenbaum M; Lima LO; Van der Sand CR; Van der Sand LC; Ferreira ME; Pires RC; Hutz MH Clin Chem Lab Med; 2012 Mar; 50(3):441-8. PubMed ID: 22505549 [TBL] [Abstract][Full Text] [Related]
18. Global analysis of genetic variation in SLCO1B1. Pasanen MK; Neuvonen PJ; Niemi M Pharmacogenomics; 2008 Jan; 9(1):19-33. PubMed ID: 18154446 [TBL] [Abstract][Full Text] [Related]
19. Marked differences in frequencies of statin therapy relevant SLCO1B1 variants and haplotypes between Roma and Hungarian populations. Nagy A; Sipeky C; Szalai R; Melegh BI; Matyas P; Ganczer A; Toth K; Melegh B BMC Genet; 2015 Sep; 16():108. PubMed ID: 26334733 [TBL] [Abstract][Full Text] [Related]
20. Frequency of functional exonic single-nucleotide polymorphisms and haplotype distribution in the SLCO1B1 gene across genetic ancestry groups in the Qatari population. Dashti M; Al-Matrouk A; Channanath A; Al-Mulla F; Thanaraj TA Sci Rep; 2022 Sep; 12(1):14858. PubMed ID: 36050458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]